Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences
DEVON, Pa., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the …